Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
Quadri Pharma will cover 50% of the costs of development activity up to a capped dollar contributionJaguar to host virtual...